Central Govt. extends timeline for submission of applications under the ‘PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials / Drug Intermediates and APIs’ till 31st March, 2022

Central Govt. extends timeline for submission of applications under the ‘PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials / Drug Intermediates and APIs’ till 31st March, 2022

Central Govt. extends timeline for submission of applications under the ‘PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials / Drug Intermediates and APIs’ till 31st March, 2022

by Lexplosion | Mar 25, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017

DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017

by Lexplosion Solution | Aug 27, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Manufacturers and importers of knee implants directed to furnish pricing data on orthopedic knee implants (for knee replacement system) by 12th August, 2021 in format prescribed by the pricing authority

Manufacturers and importers of knee implants directed to furnish pricing data on orthopedic knee implants (for knee replacement system) by 12th August, 2021 in format prescribed by the pricing authority

by Lexplosion | Aug 9, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

CDSCO proposes the Draft New Drugs and Clinical Trials (Amendment) Rules, 2021; invites objections/suggestions by 14th September, 2021

CDSCO proposes the Draft New Drugs and Clinical Trials (Amendment) Rules, 2021; invites objections/suggestions by 14th September, 2021

by Lexplosion | Aug 5, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Department of Commerce restricts the export of Remdesivir Injection & Remdesivir Active Pharmaceutical Ingredients (API) ; no separate export authorization will be required

by Lexplosion Solution | Jun 17, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

NCT, Delhi orders authorized dealers of pulse Oxymeter and Oxygen Concentrator to display the Stock position and MRP of these devices at their premises for general public

by Lexplosion Solution | May 28, 2021 | Delhi, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

« Older Entries

Next Entries »